GirardC, LehotJJ, PannetierJC, FilleyS, FfrenchP, EstanoveS.Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology1992;77(5):880–883.
5.
SnowDJ, GraySJ, GhoshS, FoubertL, OduroA, HigenbottamTW, WellsFC, LatimerRD.Inhaled nitric oxide in patients with normal and increased pulmonary vascular resistance after cardiac surgery. Br J Anaesth1994;72(2):185–189.
KayeMP.The Registry of the International Society for Heart and Lung Transplantation: tenth official report—1993. J Heart Lung Transplant1993;12(4):541–548.
8.
Kieler-JensenN, RickstenSE, StenqvistO, BerghCH, LindelovB, WennmalmA, et al. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant1994;13(3):366–375.
9.
SpezialeG, De BiaseL, De VincentisG, LerardiM, RuvoloG, La FrancesscaS, et al. Inhaled nitric oxide in patients with severe heart failure: changes in lung perfusion and ventilation detected using scintigraphy. Thorac Cardiovasc Surg1996;44(1):35–39.
10.
SnellGL, SalamonsenRF, BerginP, EsmoreDS, KhanS, WilliamsTJ.Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension. Am J Respir Crit Care Med1995;151(4):1263–1266.
11.
ChenEP, BittnerHB, DavisRDJr, Van Trigt3rd.Effects of nitric oxide after cardiac transplantation in the setting of recipient pulmonary hypertension. Ann Thorac Surg1997;63(6):1546–1555.
12.
Kieler-JensenN, LundinS, RickstenSE.Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside. J Heart Lung Transplant1995;14(3):436–443.
13.
GirardC, DurandPG, VedrinneC, PannetierJC, EstanoveS, FalkeK, et al. Case 4—1993 inhaled nitric oxide for right ventricular failure after heart transplantation. J Cardiothorac Vasc Anesth1993;7(4):481–485.
14.
FrazierOH, RoseEA, MacmanusQ, BurtonNA, LefrakEA, PoirierVL, DasseKA.Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg1992;53(6):1080–1090.
15.
ArgenzianoM, ChoudhriA, MoazamiN, RoseEA, SmithCR, LevinHR, et al. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg1998;65(2):340–345.
16.
WagnerF, DandelM, GuntherG, LoebeM, Schulze-NeickI, LauckeU, et al. Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation. Circulation1997;96(9 Suppl):II-291–II-296.
17.
FierobeL, BrunetF, DhainautJF, MonchiM, BelghithM, MiraJP, et al. Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome. Am J Respir Crit Care Med1995;151(5):1414–1419.
18.
RossaintR, SlamaK, SteudelW, GerlachH, PappertD, VeitS, FalkeK.Effects of inhaled nitric oxide on right ventricular function in severe acute respiratory distress syndrome. Intensive Care Med1995;21(3):197–203.
19.
BenzingA, MolsG, BeyerU, GeigerK.Large increase in cardiac output in a patient with ARDS and acute right heart failure during inhalation of nitric oxide. Acta Anaesthesiol Scand1997;41(5):643–647.
20.
LohE, StamlerJS, HareJM, LoscalzoJ, ColucciWS.Cardiovas-cular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation1994;90(6):2780–2785.
21.
AdatiaI, PerryS, LandzbergM, MooreP, ThompsonJE, WesselDL.Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. J Am Coll Car-diol1995;25(7):1656–1664.
22.
SemigranMJ, CockrillBA, KacmarekR, ThompsonBT, ZapolWM, DecGW, FiferMA.Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol1994;24(4):982–988.
23.
BocchiEA, BacalF, AulerOCJr, CarmoneMJ, BellottiG, PileggiF.Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. Am J Cardiol1994;74(1):70–72.
24.
DicksteinML, BurkhoffD.A theoretic analysis of the effect of pulmonary vasodilation on pulmonary venous pressure: implications for inhaled nitric oxide therapy. J Heart Lung Transplant1996;15(7):715–721.
25.
HareJM, ShernonSK, BodySC, GraydonE, ColucciWS, CouperGS.Influence of inhaled nitric oxide on systemic flow and ventric-ular filling pressure in patients receiving mechanical circulatory assistance. Circulation1997;95(9):2250–2253.
26.
FinkelM, OddisCV, JacobTD, WatkinsSC, HattlerBG, SimmonsRL.Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science1992;257(5068):387–389.
HareJM, LohE, CreagerMA, ColucciWS.Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation1995;92(8):2198–2203.
29.
HareJM, GivertzMM, CreagerMA, ColucciWS.Increased sensi-tivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic inotropic responsiveness. Circulation1998;97(2):161–166.
30.
Ungureanu-LongroisD, BalligandJL, KellyRA, SmithTW.Myo-cardial contractile dysfunction in the systemic inflammatory response syndrome: role of cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol1995;27(1):155–167.
31.
ArgenzianoM, DeanDA, MoazamiN, GoldsteinDJ, RoseEA, SpotnitzHM, et al. Inhaled nitric oxide is not a myocardial depres-sant in a porcine model of heart failure. J Thorac Cardiovasc Surg1998;115(3):700–708.
32.
HaywardCS, KalninsWV, RogersP, FeneleyMP, MacDonaldPS, KellyRP.Effect of inhaled nitric oxide on normal human left ven-tricular function. J Am Coll Cardiol1997;30(1):49–56.
33.
KoellingTM, KirmseM, Di SalvoTG, DecGW, ZapolWM, SemigranMJ.Inhaled nitric oxide improves exercise capacity in patients with severe heart failure and right ventricular dysfunction. Am J Cardiol1998;81(12):1494–1497.
34.
AtzAM, AdatiaI, JonasRA, WesselDL.Inhaled nitric oxide in children with pulmonary hypertension and congenital mitral steno-sis. Am J Cardiol1996;77(4):316–319.
35.
WesselDL, AdatiaI, GigliaTM, ThompsonJE, KulikTJ.Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation1993;88(5 Pt 1):2128–2138.
36.
GamillschegA, ZobelG, UrlesbergerB, BergerJ, DacarD, SteinJI, RiglerB, et al. Inhaled nitric oxide in patients with critical pulmo-nary perfusion after Fontan-type procedures and bidirectional Glenn anastomosis. J Thorac Cardiovasc Surg1997;113(3):435–442.
37.
LucianiGB, PessottoR, MazzuccoA.Recurrence of pulmonary hypertension after ventricular septal defect closure and perioperative response to nitric oxide. Int J Cardiol1998;63(1):85–87.
38.
RussellIA, ZwassMS, FinemanJR, BaleaM, Rouine-RappK, BrookM, et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesth Analg1998;87(1):46–51.
39.
Schulze-NeickI, BultmannM, WernerH, GammillschegA, VogelM, BergerF, et al. Right ventricular function in patients treated with inhaled nitric oxide after cardiac surgery for congenital heart disease. Am J Cardiol1997;80(3):360–363.
40.
AdatiaI, AtzAM, JonasRA, WesselDL.Diagnostic use of inhaled nitric oxide after neonatal cardiac operations. J Thorac Cardiovasc Surg1996;112(5):1403–1405.
TibballsJ.Clinical applications of gaseous nitric oxide. Anaesth Intensive Care1993;21(6):866–871.
43.
SelldenH, WinbergP, GustafssonLE, LundellB, BookK, FrostellCG.Inhalation of nitric oxide reduced pulmonary hypertension after cardiac surgery in a 3.2-kg infant. Anesthesiology1993;78(3):577–580.
44.
BernerM, BeghettiM, RicouB, RougeJC, PretreR, FriedliB.Relief of severe pulmonary hypertension after closure of a large ventricular septal defect using low dose inhaled nitric oxide. Inten-sive Care Med1993;19(2):75–77.
45.
HealCA, SpencerSA.Methaemoglobinaemia with high-dose nitric oxide administration. Acta Paediatr1995;84(11):1318–1319.
46.
NakajimaW, IshidaA, AraiH, TakadaG.Methaemoglobinaemia after inhalation of nitric oxide in infant with pulmonary hypertension (letter). Lancet1997;350(9083):1002–1003.
47.
LavoieA, HallJB, OlsonDM, WylamME.Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am J Respir Crit Care Med1996;153(6 Pt 1):1985–1987.
48.
CuthbertsonBH, DellingerP, DyarOJ, EvansTE, HigenbottamT, LatimerR, et al. UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. American-European Consensus Conference on ALI/ARDS. Intensive Care Med1997;23(12):1212–1218.
